AKT1 and melanoma: Apart from the already mentioned antileishmanial [23] and moderate antimicrobial [54] effects, the compound demonstrated promising activity as an inhibitor of pathological activities of protein kinase B (Akt) and extracellular signal-regulated kinases (ERKs) in human melanoma cells [55].